Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| SRC | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 345.0 | Evidence | |||||
| SRC | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
| SRC | CRKL | CRKL: Crk-like protein | 275.0 | Evidence | |||||
| SRC | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 275.0 | Evidence |
|
||||
| SRC | NCK2 | NCK2: Cytoplasmic protein NCK2 | 223.0 | Evidence | |||||
| SRC | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 221.0 | Evidence | |||||
| SRC | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 209.0 | Evidence | |||||
| SRC | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 206.0 | Evidence |
|
||||
| SRC | EPHB4 | EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor | 206.0 | Evidence | |||||
| SRC | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 206.0 | Evidence | |||||
| SRC | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 181.0 | Evidence |
|
||||
| SRC | LYN | LYN: Tyrosine-protein kinase Lyn | 181.0 | Evidence | |||||
| SRC | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 181.0 | Evidence | |||||
| SRC | SYK | SYK: Tyrosine-protein kinase SYK | 181.0 | Evidence |
|
||||
| SRC | CSK | CSK: Tyrosine-protein kinase CSK | 181.0 | Evidence |
|
||||
| SRC | HCK | N/A | 180.0 | Evidence | |||||
| SRC | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 180.0 | Evidence |
|
||||
| SRC | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 167.0 | Evidence |
|
||||
| SRC | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | KIT | KIT: Mast/stem cell growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 167.0 | Evidence | |||||
| SRC | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 156.0 | Evidence |
|
||||
| SRC | STAT3 | 156.0 | Evidence |
|
|||||
| SRC | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 147.0 | Evidence | |||||
| SRC | APS | SH2B2, APS: SH2B adapter protein 2 | 137.0 | Evidence | |||||
| SRC | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 137.0 | Evidence | |||||
| SRC | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 137.0 | Evidence |
|
||||
| SRC | VAV1 | VAV1, VAV: Proto-oncogene vav | 137.0 | Evidence | |||||
| SRC | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence |
|
||||
| SRC | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 135.0 | Evidence | |||||
| SRC | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 119.0 | Evidence | |||||
| SRC | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| SRC | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence |
|
||||
| SRC | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence |
|
||||
| SRC | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 117.0 | Evidence |
|
||||
| SRC | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 117.0 | Evidence | |||||
| SRC | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 109.0 | Evidence | |||||
| SRC | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 109.0 | Evidence | |||||
| SRC | INSR | INSR: Insulin receptor precursor | 101.0 | Evidence |
|
||||
| SRC | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 89.30 | Evidence |
|
||||
| SRC | JAK1 | 88.80 | Evidence | ||||||
| SRC | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 87.30 | Evidence | |||||
| SRC | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 82.10 | Evidence | |||||
| SRC | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 78.20 | Evidence | |||||
| SRC | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 76.90 | Evidence | |||||
| SRC | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 76.90 | Evidence |
|
||||
| SRC | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 66.50 | Evidence | |||||
| SRC | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 66.50 | Evidence |
|
||||
| SRC | GRB10 | N/A | 56.20 | Evidence |
|
||||
| SRC | GRAP | GRAP: GRB2-related adapter protein | 29.10 | Evidence | |||||
| SRC | DOK1 | DOK1: Docking protein 1 | 27.90 | Evidence |
|
||||
| SRC | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 26.40 | Evidence |
|
||||
| SRC | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 26.40 | Evidence | |||||
-